You are here
SORRENTO THERAPEUTICS, INC.
http://www.sorrentotherapeutics.com
UEI: KWEWLHZ59FL3
# of Employees: 65
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Human Anti-WISP1 Antibodies for Treatment of Idiopathic Pulmonary Fbrosis
Amount: $224,823.00DESCRIPTION (provided by applicant): New anti-fibrotic drugs are needed to treat Idiopathic Pulmonary Fibrosis (IPF). IPF is a progressive, chronically debilitating clinical syndrome with unknown etio ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Targeting of Myc-Max dimerization for the treatment of cancer
Amount: $224,550.00DESCRIPTION (provided by applicant): Myc is a key transcriptional regulator due to its critical role in many fundamental cellular processes, such as cell cycle progression and cell growth. Therefore, ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
Human monoclonal antibodies for prevention of S. aureus infections
Amount: $1,997,627.00DESCRIPTION provided by applicant Using mouse monoclonal antibodies mAbs raised against the mediators of quorum sensing QS the Auto Inducing Peptides AIPs researchers at The Scripps Researc ...
STTRPhase II2014Department of Health and Human Services National Institutes of Health -
Anti-Pseudomonas Immunotherapy and Targeted Drug Delivery
Amount: $586,535.00DESCRIPTION provided by applicant Antibody therapy for serious bacterial infections using polyclonal immune antitoxin or anti capsule horse serum actually predates small molecule antibiotic use Ho ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
Human monoclonal antibodies for prevention of S. aureus infections
Amount: $597,832.00DESCRIPTION (provided by applicant): Using mouse monoclonal antibodies (mAbs) raised against the mediators of quorum sensing (QS), the Auto-Inducing Peptides (AIPs), researchers at The Scripps Researc ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health -
A vaccine against Clostridium difficile infections
Amount: $598,689.00DESCRIPTION (provided by applicant): In this proposal we lay out a comprehensive research plan to evaluate our vaccination strategies targeting Clostridium difficile to prevent or treat infections. W ...
STTRPhase I2011Department of Health and Human Services National Institutes of Health -
Evaluation of Staphylococcus aureus agr-based Quorum Sensing as Vaccine Candidate
Amount: $600,000.00DESCRIPTION (provided by applicant): In this proposal we lay out a comprehensive research plan to evaluate our passive vaccination strategies targeting Staphylococcus aureus/MRSA to prevent or treat ...
STTRPhase I2010Department of Health and Human Services National Institutes of Health
